Interní Med. 2017; 19(1): 23-27 | DOI: 10.36290/int.2017.047

Modern technology in diabetes treatment – what is new?

prof. MUDr. Kateřina Štechová, Ph.D.
Interní klinika UK 2. LF a FN v Motole

Technique is more and more employed in a management of patients treated for all diabetes types. Modern technical approach is

particularly helpful in following areas: selfmonitoring, insulin delivery and patient´s safety (prevention of serious hypoglycaemia

occurrence) but can be helpful in the monitoring of nutritional intake or physical activity as well.

There is a trend to use smart phones in diabetes management for example as receivers for continuous glucose monitoring. By

using mobile applications (which can be installed into smartphones) patient´s data analysis can be provided too. Modern devices

are constructed nowadays to use preferentially wireless technology. In this article innovations, currently available in the Czech

Republic for insulin pump treatment and glycaemic selfmonitoring are discussed.

Keywords: diabetes, technique, glycaemic selfmonitoring, continuous glucose monitoring, insulin pump

Received: March 11, 2019; Accepted: April 10, 2019; Prepublished online: April 10, 2019; Published: February 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štechová K. Modern technology in diabetes treatment – what is new? Interní Med. 2017;19(1):23-27. doi: 10.36290/int.2017.047.
Download citation

References

  1. http://www.diab.cz/dokumenty/testovani_glukometry_2014.pdf Staženo 14.11.2016.
  2. https://www.fel.cvut.cz/cz/aktuality/revolucni-bezbateriovy-glukometr-z-fakulty-elektrotechnicke-nabijete-z-mobilu-a-kdykoliv-zobrazi-namerene-hodnoty-cukru Staženo 14.11.2016.
  3. Clark LC Jr, Lyons C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann N Y Acad Sci. 1962; 102: 29-45. Go to original source... Go to PubMed...
  4. Štechová K. Kontinuální monitorace koncentrace glukózy (CGM). In: Štechová K(ed).Technologie v diabetologii. Maxdorf Praha 2016, 25-52.
  5. Liebl A, Henrichs HR, Heinemann L, et al. Continuous Glucose Monitoring Working Group of the Working Group Diabetes Technology of the German Diabetes Association. Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol. 2013; 7(2): 500-519. Go to original source... Go to PubMed...
  6. Bailey T, Bode BW, Christiansen MP, Klaff LJ, Alva S. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther. 2015; 17(11): 787-794. Go to original source... Go to PubMed...
  7. Všeobecná zdravotní pojišťovna. Úhradový katalog VZP-ZP. Metodika. Verze 989. Platnost od 1.1.2017 Dostupný on-line https://www.vzp.cz/poskytovatele/ciselniky/zdravotnicke-prostredky; staženo 31.1.2017.
  8. www.diasend.com.
  9. Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol. 2013; 7(2): 562-578. Go to original source... Go to PubMed...
  10. Hou C, Carter B, Hewitt J, Francisa T, Mayor S. Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials.Diabetes Care. 2016; 39(11): 2089-2095. Go to original source... Go to PubMed...
  11. Kaufman N, Bian RR. Using health information technology to prevent and treat diabetes. Diabetes Technol Ther.2015; 17(Suppl 1): S53-66. Go to original source... Go to PubMed...
  12. Štechová K. Léčba inzulínovou pumpou. In: Štechová K (ed). Technologie v diabetologii. Maxdorf Praha 2016, str. 61-95.
  13. Layne JE, Parkin CG, Zisser H. Efficacy of a Tubeless Patch Pump in Patients With Type 2 Diabetes Previously Treated With Multiple Daily Injections. J Diabetes Sci Technol. 2016 Jun 11. pii: 1932296816653143. Go to original source... Go to PubMed...
  14. http://www.diab.cz/dokumenty/standard_pumpa.pdf
  15. U.S. Food and Drug Administration. The Mobile Medical Applications Guidance for Industry and Food and Drug Administration Staff. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf#page=20 Staženo 22.1.2017.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.